Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PENGUIN: Bevacizumab-800CW for Intraoperative Detection of Pancreatic Cancer
NCT02743975Phase 2Terminated
- Sponsor
- University Medical Center Groningen
- Start
- Dec 2016
- Primary completion
- Feb 2018
- Modality
- Monoclonal Antibodies, Antibody-Drug Conjugates (ADCs)
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab-IRDye800CW in pancreatic cancer (PC), sponsored by University Medical Center Groningen. Started Dec 2016; status: terminated.
02
Drugs
bevacizumab-IRDye800CW
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT02743975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02743975.